Developing next generation treatments to preserve vision for patients with diseases affecting the back of the eye

OXURION to Participate in Upcoming Investor Meetings

5 Aug 2021

Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company developing next generation standard of care ophthalmic therapies, with a clinical stage portfolio in vascular retinal disorders, today announces its management will participate and meet with investors at the following upcoming virtual meetings: 

  • 2021 Wedbush PacGrow Healthcare Virtual Conference - August 10-11, 2021

Panel presentation (Goldeneye) scheduled on August 11 at 9:45 AM ET

  • H.C. Wainwright Ophthalmology Conference - August 17, 2021

Pre-Recorded CEO Presentation available starting on August 17 at 7:00 AM ET

Panel presentation (Vision Repair Beyond Traditional Anti-VEGF) scheduled on August 17 at 12:00 PM ET


For more information, please visit Oxurion’s events page.



Press release attachment: 
Company; THR-149; THR-687; Investors